In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Hakan Goker, Vice President of M Ventures. Hakan gives a unique insight into how both COVID-19 and Brexit are affecting current investment opportunities for both investors and start-ups, including restrictions on travel, face to face pitching and pipeline requirements. He talks about the increasing importance on making sure all written communications and presentations are clear and sharp in this era to help executives secure and access finance, as well as patience while VC’s focus on existing partnerships. Hakan also gives an overview of the benefits of work with corporate VC’s, such as M Ventures, and how they minimize cross-contamination with the biotech and their pharma company. Hosted on Acast. See acast.com/privacy for more information.